# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as fo...
Company aligned with FDA on key CMC topicsTonix also has completed the second and final pre-New Drug Application (NDA) meeting ...
Treatment with Tonmya™ (TNX-102 SL, sublingual cyclobenzaprine HCl) in Phase 3 RESILIENT study significantly reduced daily pain...